167 related articles for article (PubMed ID: 38709233)
1. Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancer.
Duggan WP; Kisakol B; Woods I; Azimi M; Dussmann H; Fay J; O'Grady T; Maguire B; Reynolds IS; Salvucci M; Slade DJ; McNamara DA; Burke JP; Prehn JHM
Gut Microbes; 2024; 16(1):2350149. PubMed ID: 38709233
[TBL] [Abstract][Full Text] [Related]
2. Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome.
Duggan WP; Salvucci M; Kisakol B; Lindner AU; Reynolds IS; Dussmann H; Fay J; O'Grady T; Longley DB; Ginty F; Mc Donough E; Slade DJ; Burke JP; Prehn JHM
J Mol Med (Berl); 2023 Jul; 101(7):829-841. PubMed ID: 37171483
[TBL] [Abstract][Full Text] [Related]
3. Multiplexed Immunofluorescence Imaging Reveals an Immune-Rich Tumor Microenvironment in Mucinous Rectal Cancer Characterized by Increased Lymphocyte Infiltration and Enhanced Programmed Cell Death Protein 1 Expression.
Duggan WP; Kisakol B; O'Connell E; Matveeva A; O'Grady T; McDonough E; Lindner AU; McNamara D; Longley D; Ginty F; Burke JP; Prehn JHM
Dis Colon Rectum; 2023 Jul; 66(7):914-922. PubMed ID: 36525395
[TBL] [Abstract][Full Text] [Related]
4. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
Liu H; Zhang Z; Zhen P; Zhou M
J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
[TBL] [Abstract][Full Text] [Related]
5. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
[TBL] [Abstract][Full Text] [Related]
6. Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer.
Wilkins A; Fontana E; Nyamundanda G; Ragulan C; Patil Y; Mansfield D; Kingston J; Errington-Mais F; Bottomley D; von Loga K; Bye H; Carter P; Tinkler-Hundal E; Noshirwani A; Downs J; Dillon M; Demaria S; Sebag-Montefiore D; Harrington K; West N; Melcher A; Sadanandam A
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33678606
[TBL] [Abstract][Full Text] [Related]
7. Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients.
Yasui K; Kondou R; Iizuka A; Miyata H; Tanaka E; Ashizawa T; Nagashima T; Ohshima K; Urakami K; Kusuhara M; Muramatsu K; Sugino T; Yamguchi K; Mori K; Harada H; Nishimura T; Kagawa H; Yamakawa Y; Hino H; Shiomi A; Akiyama Y
J Radiat Res; 2020 Sep; 61(5):766-775. PubMed ID: 32672335
[TBL] [Abstract][Full Text] [Related]
8. Mucinous adenocarcinoma of the colon and rectum: A genomic analysis.
Reynolds IS; O'Connell E; Fichtner M; McNamara DA; Kay EW; Prehn JHM; Furney SJ; Burke JP
J Surg Oncol; 2019 Dec; 120(8):1427-1435. PubMed ID: 31729037
[TBL] [Abstract][Full Text] [Related]
9. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
10. Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor.
Yeoh YK; Chen Z; Wong MCS; Hui M; Yu J; Ng SC; Sung JJY; Chan FKL; Chan PKS
Gut; 2020 Nov; 69(11):1998-2007. PubMed ID: 32051205
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma.
Farchoukh L; Hartman DJ; Ma C; Celebrezze J; Medich D; Bahary N; Frank M; Pantanowitz L; Pai RK
Mod Pathol; 2021 Jan; 34(1):171-183. PubMed ID: 32661298
[TBL] [Abstract][Full Text] [Related]
12. Ca
Kumar R; Raman R; Kotapalli V; Gowrishankar S; Pyne S; Pollack JR; Bashyam MD
J Mol Med (Berl); 2018 Feb; 96(2):135-146. PubMed ID: 29124284
[TBL] [Abstract][Full Text] [Related]
13. Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.
Alderdice M; Dunne PD; Cole AJ; O'Reilly PG; McArt DG; Bingham V; Fuchs MA; McQuaid S; Loughrey MB; Murray GI; Samuel LM; Lawler M; Wilson RH; Salto-Tellez M; Coyle VM
Mod Pathol; 2017 Sep; 30(9):1287-1298. PubMed ID: 28621318
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis.
Roelands J; van der Ploeg M; Ijsselsteijn ME; Dang H; Boonstra JJ; Hardwick JCH; Hawinkels LJAC; Morreau H; de Miranda NFCC
Gut; 2023 Jul; 72(7):1326-1339. PubMed ID: 36442992
[TBL] [Abstract][Full Text] [Related]
15. Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis.
Zhang Q; Liu Y; Wang X; Zhang C; Hou M; Liu Y
Front Immunol; 2023; 14():1184167. PubMed ID: 37675100
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Lin A; Zhang J; Luo P
Front Immunol; 2020; 11():2039. PubMed ID: 32903444
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic subtypes predict outcomes in colorectal cancer.
Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
[TBL] [Abstract][Full Text] [Related]
18. Metastatic role of mammalian target of rapamycin signaling activation by chemoradiotherapy in advanced rectal cancer.
Shiratori H; Kawai K; Okada M; Nozawa H; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Kaneko M; Murono K; Emoto S; Ishii H; Sonoda H; Ushiku T; Ishihara S
Cancer Sci; 2020 Apr; 111(4):1291-1302. PubMed ID: 31997546
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
[TBL] [Abstract][Full Text] [Related]
20. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
